IP Library Granted Patent US 8,889,385
Granted Patent B2
US 8,889,385 · App. 13/838,949 · Granted Nov 18, 2014

Fermentive production of four carbon alcohols

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,889,385
App. No.
13/838,949
Granted
Nov 18, 2014
Kind
B2
Abstract

Methods for the fermentative production of four carbon alcohols is provided. Specifically, butanol, preferably isobutanol is produced by the fermentative growth of a recombinant bacterium expressing an isobutanol biosynthetic pathway.

Claims (22)

1. A method comprising:

(a) determining the acetohydroxy acid isomeroreductase (KARI) activity of a cell free extract prepared from a host cell expressing a heterologous KARI enzyme; and

(b) expressing a heterologous DNA molecule encoding the KARI enzyme in a recombinant microorganism expressing an engineered isobutanol biosynthetic pathway,

wherein the cell free extract comprises higher KARI activity than a control cell free extract prepared from a host cell not expressing the heterologous KARI enzyme, and

wherein the recombinant microorganism is capable of bioproducing isobutanol suitable for use in fuel cells or vehicles.

2. The method of claim 1 , wherein the host cell of (a) is E. coli.

3. The method of claim 1 , wherein the recombinant microorganism is selected from the group consisting of: a bacterium, a cyanobacterium, a filamentous fungus and a yeast.

4. The method of claim 3 , wherein the recombinant microorganism is yeast.

5. The method of claim 1 , wherein the recombinant microorganism is Saccharomyces cerevisiae.

6. The method of claim 1 , wherein the recombinant microorganism using glucose as a carbon source produces more isobutanol than a control microorganism not expressing the engineered biosynthetic isobutanol pathway.

7. The method of claim 1 , wherein the recombinant microorganism comprises an inactivated gene that reduces yield loss from competing pathways for carbon flow.

8. The method of claim 1 , wherein the engineered biosynthetic isobutanol pathway comprises an acetolactate synthase (ALS) enzyme, a KARI enzyme, an acetohydroxy acid dehydratase (DHAD) enzyme, a branched chain keto acid decarboxylase enzyme, and a branched-chain alcohol dehydrogenase (ADH) enzyme, each of which is encoded by a heterologous DNA molecule.

9. The method of claim 1 , wherein the engineered biosynthetic isobutanol pathway comprises an ALS enzyme, a KARI enzyme, a DHAD enzyme, a branched-chain keto acid dehydrogenase enzyme, an acylating aldehyde dehydrogenase enzyme, and an ADH enzyme, each of which is encoded by a heterologous DNA molecule.

10. The method of claim 1 , wherein the engineered biosynthetic isobutanol pathway comprises an ALS enzyme, a KARI enzyme, a DHAD enzyme, at least one of a transaminase enzyme and a valine dehydrogenase enzyme, a valine decarboxylase enzyme, an omega transaminase enzyme, and an ADH enzyme, each of which is encoded by a heterologous DNA molecule.

11. The method of claim 8 , wherein the branched chain keto acid decarboxylase enzyme has 50-200-fold preference for ketoisovalerate over pyruvate.

12. The method of claim 8 , wherein the ALS, KARI, DHAD, branched chain keto acid decarboxylase, and ADH enzymes each lack a mitochondrial targeting sequence.

13. The method of claim 8 , wherein the ALS enzyme has an EC number of 2.2.1.6, the KARI enzyme has an EC number of 1.1.1.86, the DHAD enzyme has an EC number of 4.2.1.9, the branched chain keto acid decarboxylase enzyme has an EC number of 4.1.1.72, and the ADH enzyme has an EC number of 1.1.1.1, 1.1.1.2, or 1.1.1.265.

14. The method of claim 13 , wherein the ALS enzyme has an amino acid sequence selected from SEQ ID NOs: 2, 178, and 180.

15. The method of claim 13 , wherein the KARI enzyme has an amino acid sequence selected from SEQ ID NOs: 4, 181, 183, and 185.

16. The method of claim 13 , wherein the DHAD enzyme has an amino acid sequence selected from SEQ ID NOs: 6, 186, 188, and 190.

17. The method of claim 13 , wherein the branched chain keto acid decarboxylase enzyme has an amino acid sequence selected from SEQ ID NOs: 8, 193, 195, and 197.

18. The method of claim 1 , wherein the recombinant microorganism is capable of bioproducing isobutanol as a single product.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 30, 2021
From: BUTAMAX ADVANCED BIOFUELS LLC
To: GEVO, INC.
Reel/Frame 057677/0477 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 27, 2021
From: DONALDSON, GAIL K.; ELIOT, ANDREW C.; FLINT, DENNIS; MAGGIO-HALL, LORI ANN; NAGARAJAN, VASANTHA
To: BUTAMAX(TM) ADVANCED BIOFUELS LLC
Reel/Frame 057305/0684 →